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The Myc proto-oncogene has been intensively studied in tumorigenesis and development. A new
paper in Cell reports the role of Myc as a determinant of mammalian longevity. Myc heterozygous
mice exhibit extended lifespans resulting from alterations in multiple cellular processes distinct
from those observed in other longevity models.Myc ranks among the most exhaustively
studied genes in the vertebrate genome.
The intense interest stems from its essen-
tial and multiple roles in development and
its critical functions in the etiology of
most, if not all, cancers. The Myc protein
is thought to function predominantly as
a transcriptional regulator influencing
the expression of thousands of genes
and broadly promoting the fundamental
cellular processes of growth, metabolism,
proliferation, differentiation, and death in
a context-dependent manner (for reviews,
see Dang and Eisenman, 2014). While
Myc has been intensively studied at the
cellular level, relatively little is known con-
cerning its roles in organismal physiology.
In this issue ofCell, Sedivy and coworkers
(Hofmann et al., 2015) provide compelling
evidence that mammalian longevity and
healthspan are linked in multiple ways to
the abundance of the Myc protein.
By comparing wild-type mice (Myc+/+)
with mice expressing roughly half the
amount of Myc mRNA and protein
(Myc+/), Hofmann et al. found a 15%
increase in median lifespan (combined
for both sexes) caused by Myc hypomor-
phism. Importantly, the attenuated mor-
tality is manifested across all ages, indi-
cating that the impact of lowered Myc
levels is not restricted to a specific period
of time. This augmentation in lifespan ap-
pears to be accompanied by a diverse
group of phenotypes that are indicative
of an increased healthspan and correlate
with other long-lived mouse models,
such as calorie restricted (CR) and Ames
dwarf mice (Gems and Partridge, 2013).
These phenotypes include decreases in
body size, serum IGF1 levels, immunose-
nescence, spontaneous tumor progres-
sion, osteoporosis, and serum and liver
cholesterol content, as well as enhancedmetabolic rate and neuromuscular perfor-
mance, all of which are characteristic of
young animals and are observed in older
Myc hypomorphic mice. While pheno-
typic similarities between Myc+/ and
other lifespan-extending conditions are
apparent, there are also some significant
differences. For example, in the Myc
hypomorphic mice, no changes are de-
tected in body temperature, adiposity,
or fertility, while all three are changed
in other mouse models of increased
longevity. Moreover, meta-analyses of
gene expression profiles derived from
mice with extended lifespan due to CR
or metformin treatment reveal only few
changes in common with those from the
Myc hypomorphic mice. Together, these
data suggest that lower Myc levels pro-
mote lifespan extension through a unique
constellation of molecular events. In
addition, as the authors point out, major
consequences of decreased Myc may
be indirect and not necessarily apparent
at the transcriptional level. For instance,
diminished rates of translation or sup-
pression of mTOR activity have been
linked to lifespan extension in flies, yeast,
and nematodes (Gems and Partridge,
2013).
Previous studies in Drosophila mela-
nogaster have implicated members of
the Myc transcriptional network in the
regulation of aging. Loss-of-function al-
leles of the Drosophila Myc antagonist,
dMnt, increase cell size and body weight
while decreasing fly lifespan (Loo et al.,
2005). More recently, Drosophila Myc
has been shown to act as a rheostat
for longevity, as its overexpression di-
minishes and heterozygous deletion aug-
ments longevity in flies (Greer et al., 2013).
These phenotypes appear to be indepen-
dent of apoptosis and correlated withCell 160dMyc-induced genomic instability. In the
Myc+/ mice, while apoptosis also ap-
pears unaffected, markers of DNA dam-
age and senescence are unchanged and
cells derived from these mice are equally
sensitive to toxic chemicals compared to
the wild-type controls, suggesting that
the increased longevity and healthspan
of the Myc hypomorphic mice are not
likely to be due to resistance to genomic
instability, oxidative stress, or cellular in-
sults. However, it is yet to be determined
whether the increased healthspan and
lifespan could be due to a decreased fre-
quency of insult.
Potential candidates for driving the
longevity phenotype include diminished
serum IGF1 levels and increased meta-
bolic rate, which are shared by Myc+/
mice and the somatotropic mutant mouse
strains, such as the Ames dwarf mice, and
the CR mice (Lee and Longo, 2011).
Importantly, IGF1 regulatesmTOR activity
via the PI3K-AKT pathway, and Myc+/
mice exhibit decreased IGF1 and mTOR
activity, as well as decreased rRNA pro-
duction and translation rate. In summary,
these mice appear to display better pro-
teostasis. Consistent with these findings,
treatment with the mTOR inhibitor ra-
pamycin or haploinsufficiency of mTOR
components or targets has been shown
to lead to increased lifespan (Johnson
et al., 2013).
Alterations in metabolism, as evi-
denced by enhanced oxygen-consump-
tion and mitochondrial content and func-
tion, have also been associated with
longevity. In Drosophila, expression of
the PGC-1 transcriptional coactivator in
intestinal stem cells (ISCs) results in stim-
ulation of mitochondrial biogenesis and
oxidative phosphorylation, which limits
ISC proliferation and misdifferentiation,, January 29, 2015 ª2015 Elsevier Inc. 365
Figure 1. Myc Levels Dictate Tissue Homeostasis, Organismal Size, and Lifespan
Mice lacking the Myc gene (Myc/) exhibit embryonic lethality, whereas compared with wild-type
(Myc+/+) controls, Myc+/ mice exhibit enhanced healthspan and lifespan. The lower abundance of Myc
protein in Myc hypomorphic mice results in a reduction in the number of proliferative progenitors and in
the organ size, possibly by suppressing stem cell exhaustion and limiting the number of defective or
misdifferentiated cells within the tissue, thereby maintaining tissue homeostasis.attenuates an age-dependent loss of tis-
sue homeostasis, and promotes mainte-
nance of a functional stem cell popula-
tion characteristic of younger organisms
(Rera et al., 2011). Thus, metabolic
changes may help to maintain tissue
integrity by imposing a differentiation
pace that does not deplete somatic
quiescent stem cells. It has been well
established that Myc exerts a profound
effect on metabolic activity and mito-
chondrial function and regulates the
size of stem, progenitor, and differenti-
ated cell compartments (Dang and Ei-
senman, 2014; Freije et al., 2014; Lau-
renti et al., 2008). Indeed, Hofmann
et al. detect a higher ratio of quiescent
long-term to proliferative short-term he-
matopoietic stem cells in Myc hypomor-
phic mice. This finding suggests that
the loss of one Myc allele might be suffi-
cient to limit the maximal abundance of366 Cell 160, January 29, 2015 ª2015 ElsevieMyc protein attained during stem and
progenitor cell proliferation and differ-
entiation, thereby dampening stem cell
depletion, curtailing progenitor cell over-
growth, and positively affecting homeo-
stasis of multiple cell lineages (Figure 1).
Like most important findings, the work
of Hofmann et al. on Myc’s role in
longevity raises more questions than it
answers. One outstanding question con-
cerns the tissues that are most directly
relevant to longevity in theMyc hypomor-
phic mice. Is the longevity phenotype due
to changes in multiple tissue types, or
does one tissue predominate by trig-
gering a cascade of events that ultimately
extends both lifespan and healthspan? In
particular, do nervous system-specific
changes that lead to increased neuro-
muscular fitness and metabolic alter-
ations contribute to better healthspan?
Is the observed decrease in translationr Inc.rate sufficient to account for the decrease
in cholesterol biosynthetic enzymes and
the lower production of IGF1 in the liver
and serum?Could enhanced proteostasis
resulting from diminished translational
stress affect every tissue where protein
quality control is important? Another
interesting question is whether other
members of the extended Myc network
also play a role in regulating aging. It is
evident that the more we know about
even such a well-studied gene as Myc,
the more we have to learn.REFERENCES
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